CHANGES MONITORING IN SOME BLOOD BIOCHEMICAL PARAMETERS IN THE PHARMACOTHERAPY OF THE PATIENTS WITH DEPRESSIVE DISORDERS

The largest number and most representatives of other ethnic Slaivic women received Аmitriptylinum and Relanium. The longest was treated at Azafenum of Nogai women, the drug of choice for them was Grandaxinum, they were appointed by the smallest amount of Amitriptylinum and Relanium. The lowest dose...

Full description

Saved in:
Bibliographic Details
Main Authors: Eleonora Aslibekovna Manvelyan, Svetlana Armaisovna Stepanyan
Format: Article
Language:Russian
Published: North-Caucasus Federal University 2022-10-01
Series:Современная наука и инновации
Subjects:
Online Access:https://msi.elpub.ru/jour/article/view/1095
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849388486376816640
author Eleonora Aslibekovna Manvelyan
Svetlana Armaisovna Stepanyan
author_facet Eleonora Aslibekovna Manvelyan
Svetlana Armaisovna Stepanyan
author_sort Eleonora Aslibekovna Manvelyan
collection DOAJ
description The largest number and most representatives of other ethnic Slaivic women received Аmitriptylinum and Relanium. The longest was treated at Azafenum of Nogai women, the drug of choice for them was Grandaxinum, they were appointed by the smallest amount of Amitriptylinum and Relanium. The lowest dose course of Azafenum and Grandaxinum were in Armenian women.
format Article
id doaj-art-1d48da935aec40e18363b4dd4c3e6c6a
institution Kabale University
issn 2307-910X
language Russian
publishDate 2022-10-01
publisher North-Caucasus Federal University
record_format Article
series Современная наука и инновации
spelling doaj-art-1d48da935aec40e18363b4dd4c3e6c6a2025-08-20T03:42:18ZrusNorth-Caucasus Federal UniversityСовременная наука и инновации2307-910X2022-10-01021511541094CHANGES MONITORING IN SOME BLOOD BIOCHEMICAL PARAMETERS IN THE PHARMACOTHERAPY OF THE PATIENTS WITH DEPRESSIVE DISORDERSEleonora Aslibekovna Manvelyan0Svetlana Armaisovna Stepanyan1NCFUNCFUThe largest number and most representatives of other ethnic Slaivic women received Аmitriptylinum and Relanium. The longest was treated at Azafenum of Nogai women, the drug of choice for them was Grandaxinum, they were appointed by the smallest amount of Amitriptylinum and Relanium. The lowest dose course of Azafenum and Grandaxinum were in Armenian women.https://msi.elpub.ru/jour/article/view/1095антидепрессантытранквилизаторыдозыэтносыдепрессииженщиныantidepressantstranquilizersdosesethnic groupsdepressionwoman
spellingShingle Eleonora Aslibekovna Manvelyan
Svetlana Armaisovna Stepanyan
CHANGES MONITORING IN SOME BLOOD BIOCHEMICAL PARAMETERS IN THE PHARMACOTHERAPY OF THE PATIENTS WITH DEPRESSIVE DISORDERS
Современная наука и инновации
антидепрессанты
транквилизаторы
дозы
этносы
депрессии
женщины
antidepressants
tranquilizers
doses
ethnic groups
depression
woman
title CHANGES MONITORING IN SOME BLOOD BIOCHEMICAL PARAMETERS IN THE PHARMACOTHERAPY OF THE PATIENTS WITH DEPRESSIVE DISORDERS
title_full CHANGES MONITORING IN SOME BLOOD BIOCHEMICAL PARAMETERS IN THE PHARMACOTHERAPY OF THE PATIENTS WITH DEPRESSIVE DISORDERS
title_fullStr CHANGES MONITORING IN SOME BLOOD BIOCHEMICAL PARAMETERS IN THE PHARMACOTHERAPY OF THE PATIENTS WITH DEPRESSIVE DISORDERS
title_full_unstemmed CHANGES MONITORING IN SOME BLOOD BIOCHEMICAL PARAMETERS IN THE PHARMACOTHERAPY OF THE PATIENTS WITH DEPRESSIVE DISORDERS
title_short CHANGES MONITORING IN SOME BLOOD BIOCHEMICAL PARAMETERS IN THE PHARMACOTHERAPY OF THE PATIENTS WITH DEPRESSIVE DISORDERS
title_sort changes monitoring in some blood biochemical parameters in the pharmacotherapy of the patients with depressive disorders
topic антидепрессанты
транквилизаторы
дозы
этносы
депрессии
женщины
antidepressants
tranquilizers
doses
ethnic groups
depression
woman
url https://msi.elpub.ru/jour/article/view/1095
work_keys_str_mv AT eleonoraaslibekovnamanvelyan changesmonitoringinsomebloodbiochemicalparametersinthepharmacotherapyofthepatientswithdepressivedisorders
AT svetlanaarmaisovnastepanyan changesmonitoringinsomebloodbiochemicalparametersinthepharmacotherapyofthepatientswithdepressivedisorders